Reshape Lifesciences (RSLS) Set to Announce Earnings on Thursday
Reshape Lifesciences (NASDAQ:RSLS) will announce its earnings results after the market closes on Thursday, March 22nd.
Reshape Lifesciences (RSLS) opened at $1.43 on Thursday. Reshape Lifesciences has a 12 month low of $1.23 and a 12 month high of $7.30. The firm has a market cap of $42.84, a P/E ratio of -0.24 and a beta of 2.68.
A number of research analysts have weighed in on RSLS shares. Zacks Investment Research lowered shares of Reshape Lifesciences from a “hold” rating to a “sell” rating in a research note on Wednesday, December 6th. ValuEngine raised shares of Reshape Lifesciences from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st.
About Reshape Lifesciences
ReShape Lifesciences Inc, formerly EnteroMedics Inc, is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company’s neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve.
Receive News & Ratings for Reshape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reshape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.